[Progress and new perspective treatments of systemic fungal infections].
Wierzbicka
M
M
I Kliniki Gruźlicy i Chorób Płuc Instytutu Gruźlicy i Chorób Płuc w Warszawie.
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D015725:Fluconazole / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D009181:Mycoses / Q000628:therapy*; D018746:Systemic Inflammatory Response Syndrome / Q000517:prevention & control*
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole